Nuclear Medicine
131I MIBG BACON (R&D)
Name:
131I MIBG Bacon (R&D)
Active Principle:
131I- Meta Iodo Benzylguanidine or 131I- Iobenguane
Therapeutic Action:
It is indicated for the diagnosis and location of neuroendocrine tumors, pheochromocytoma, medullary thyroid cancer, primary neuroblastomas and their metastases, paragangliomas and thymomas, among other pathologies.
Nuclear Medicine
131I MIBG BACON (R&D)
Name:
131I MIBG Bacon (R&D)
Active Principle:
131I- Meta Iodo Benzylguanidine or 131I- Iobenguane
Therapeutic Action:
It is indicated for the diagnosis and location of neuroendocrine tumors, pheochromocytoma, medullary thyroid cancer, primary neuroblastomas and their metastases, paragangliomas and thymomas, among other pathologies.
